Exploring Mechanisms of Lang Qing Ata in Non-Alcoholic Steatohepatitis Based on Metabolomics, Network Pharmacological Analysis, and Experimental Validation
Shupei Li,1,* Hanlong Zhu,2,* Qi Zhai,2,* Yu Hou,2,* Ya Yang,2,* Haifeng Lan,3 Mingzuo Jiang,2 Ji Xuan1,2 1Department of Gastroenterology, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People’s Republic of China; 2...
Saved in:
| Main Authors: | Li S, Zhu H, Zhai Q, Hou Y, Yang Y, Lan H, Jiang M, Xuan J |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/exploring-mechanisms-of-lang-qing-ata-in-non-alcoholic-steatohepatitis-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning
by: Liu Q, et al.
Published: (2025-04-01) -
Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications
by: Ni Yangyue, et al.
Published: (2024-09-01) -
A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease
by: Hao L, et al.
Published: (2025-01-01) -
Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review
by: Feng D, et al.
Published: (2016-09-01) -
Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH
by: Jianhua Zhang, et al.
Published: (2025-04-01)